Stay updated with breaking news from Lactic acidosis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tox and Hound — Happy New Year! bye bye 2020 by evieshaffer All of us at the Tox and the Hound want to thank you, dear readers, for continuing to stick with us on this incredible and strange journey. While we haven’t been with you as much as we’ve liked, there still has been an exciting range of topics covered. We kicked off the year with the awesome and controversial post “MALA-ficence”, which then provided fuel for our Fellow Friday series. Dr. Curry, with the help of Dr. Robert Robergs, explored ‘Whence the Protons of Lactic Acidosis’, in part one and part two. Dr. Curry showed us that there is always another, deeper complexity to the story we think we understand.
Cheryl Gault promoted to Chief Operating Officer Amy Schulman stepping down from Board of Directors CAMBRIDGE, Mass., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company developing innovative medicines for people with serious diseases of the central nervous system (CNS), today announced, effective January 1, 2021, the promotions of Cheryl Gault to Chief Operating Officer and Anjeza Gjino to Chief Financial Officer. Bill Huyett, the Company’s current CFO, will continue to work part-time as a Strategic Advisor providing strategic, operational, and organizational development insight. Cyclerion also announced that Amy Schulman, Managing Director of Polaris Partners, will be stepping down from the Board of Directors. Terrance McGuire, Co-founder and General Partner of Polaris Partners, continues to serve on the Board of Directors.